Get started
Author

Imad Barjij

Observed name: Barjij, Imad
ORCID: 0009-0004-2172-1058
Observed ORCID: 0009-0004-2172-1058
OpenAlex ID: A5117819573
Immunogenic Cell Death as a Target for Combination Therapies in Solid Tumors: A Systematic Review Toward a New Paradigm in Immuno-Oncology
2025 · Imad Barjij, Meryem Meliani · Cureus · 12
PDF
Cancer stem cells and post-therapy tumour recurrence: a systematic review of mechanistic pathways and translational gaps
2025 · Imad Barjij, Meryem Meliani · ecancermedicalscience · 8
PDF
Spatial and temporal intratumoral heterogeneity in breast cancer: a systematic and conceptual review of single-cell and spatial omics studies
2026 · Imad Barjij, Oumaima Lamsyah, et al. · BMC Cancer · 6
The tumor microbiome and cancer immunotherapy: A systematic review of a new frontier beyond the gut
2025 · Imad Barjij, Meryem Meliani · Bulletin du Cancer · 5
PDF
Immunoinflammatory Mechanisms Connecting Periodontitis and Solid Tumors: A Systematic Review of Original Evidence
2025 · Houda El Ayachi, Imad Barjij, et al. · Cureus · 2
PDF
Adjuvant PD-1 or PD-L1 blockade for Merkel cell carcinoma: a systematic review and meta-analysis
2026 · Imad Barjij, Sarah Naciri, et al. · Clinical & Translational Oncology
On-treatment and early post-radiotherapy EBV-DNA dynamics in locoregionally advanced nasopharyngeal carcinoma: a systematic review
2026 · Imad Barjij, Sarah Naciri, et al. · ecancermedicalscience
PDF
Universal versus guideline-based germline multigene panel testing in solid tumors: Diagnostic yield, variant of uncertain significance burden, and clinical actionability - A systematic review with meta-analysis
2026 · Imad Barjij, Sarah Naciri, et al. · Genetics in Medicine
Compartment-dependent prognostic meaning of Neuropilin-1 in solid tumors: a systematic review and meta-analysis
2026 · Imad Barjij
Baseline and On-Treatment Absolute Lymphocyte Count-Defined Lymphopenia in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review With Structured Qualitative Synthesis
2026 · Badr Cherradi, Matthieu Pallandre, et al. · Cureus
Post-neoadjuvant and peri-operative ctDNA-defined minimal residual disease in triple-negative breast cancer: a systematic review and meta-analysis
2026 · Imad Barjij, Sarah Naciri, et al. · Breast Cancer Research and Treatment
Additional file 1 of Spatial and temporal intratumoral heterogeneity in breast cancer: a systematic and conceptual review of single-cell and spatial omics studies
2026 · Imad Barjij, Oumaima Lamsyah, et al. · Figshare
Spatial and temporal intratumoral heterogeneity in breast cancer: a systematic and conceptual review of single-cell and spatial omics studies
2026 · Imad Barjij, Oumaima Lamsyah, et al. · Figshare
Interpreting neoadjuvant endocrine therapy duration in early HR-positive HER2-negative breast cancer: a systematic review and meta-analysis
2026 · Barjij, Imad
Risque de rechute dans le cancer colique localisé : paradoxe pronostique entre le stade II et le stade III
2024 · Barjij, Imad, Cherradi, Badr
Works count: 15
Citation count: 33
H-index: 4
I10-index: 1
Year
Topic
Type